









































Pa
ge

 
1



Pa
ge

 
1

 American Journal of  Medical Science
and Innovation (AJMSI)

Impact of  Unrestricted Drug Use on Psychiatric and Behavioral Disorders: Exploring 
Mental Health Effects in the United States   

Excel Onajite Ernest-Okonofua1*, Franklin ibadin1, Aminu Sufu Mahmud2, Ifeoma Theodora Abengowe1,
Ogheneyemarho Great Oyiborhoro1

Volume 4 Issue 2, Year 2025
ISSN: 2836-8509 (Online)

DOI: https://doi.org/10.54536/ajmsi.v4i2.4036
https://journals.e-palli.com/home/index.php/ajmsi

Article Information ABSTRACT

Received: November 24, 2024

Accepted: December 21, 2024

Published: July 05, 2025

Illicit substance abuse in the United States remains a public health concern as a survey shows 
that 59% of  the population aged 12 or older use illicit substances in a year. Legal highs 
such as marijuana, opioids, synthetic cannabis, and other substances are responsible for high 
addiction rates and mental illness. Issues like legalization, online drugs, and polydrug use 
only make these issues worse. Special groups are particularly vulnerable to getting treatment 
hence making the effects of  substance use not only societal but individual as well. This 
research aims to establish the correlation between the use of  drugs without prescription 
and mental illness. It also details how the availability of  drugs affects mental health and 
looks at how to prevent or treat the problem effectively. A cross-sectional survey design 
was employed, and the quantitative data collected from 378 participants was analysed. Data 
was collected with the help of  online questionnaires, including participants’ background 
information, their drug-taking behaviour, and psychiatric disorders. Descriptive analysis 
was performed utilising the SPSS statistical tool to compare the data sets. The study shows 
a positive correlation between substance use and the presence of  psychiatric disorders, 
including anxiety, depression and psychosis. The participants well understand these links 
and there was an appreciation of  early intervention and integrated care models of  treatment. 
However, there are still gaps in the treatment, especially among the marginalised groups 
of  society. The study highlights the need to increase awareness of  the disease, improve 
treatment access, and to deliver specific interventions. Approaches that address education, 
equal access to treatment, and stigma are essential interventions for addressing the two risks 
posed by substance use and related mental health effects.

Keywords
Drug Accessibility, Integrated Care, 
Mental Health Disorders, Public 
Awareness, Substance Abuse

1  Department of  Public Health, Igbinedion University, Nigeria 
2  Department of  Mental Health, University of  South Alabama, United States
* Corresponding author’s e-mail: excel_onajite@outlook.com

INTRODUCTION 
Drug use in the United States is a widespread and tangled 
public health issue of  which individuals use both legal 
and illegal ways to become addicted to these substances 
(Mack, 2017). National Survey on Drug Use and Health 
(NSDUH) that about 59% of  Americans 12 or older 
used illicit drugs in the past year with marijuana the most 
commonly used substance (Azofeifa-Ujueta, 2023). Apart 
from marijuana, most individuals use other drugs, like 
cocaine, methamphetamines, hallucinogens, and opioids, 
leading to widespread addiction and health problems 
(Azofeifa, 2019). In particular, the opioid crisis has been 
so gruesome, with over 70,000 cases of  overdose reported 
annually attributed to synthetic opioids such as fentanyl 
(Larkin Jr & Madras, 2019). Another area of  concern is 
the misuse of  prescription drugs, as at least 16 million 
Americans are believed to misuse prescription medicines 
to ease pain or spur energy, and tranquilize their anxieties 
(Preuss et al., 2019). The landscape is made more complex 
by a rise in polydrug use, individuals taking more than 
one substance at a time, which heightens health risks and 
increases the risk for a mental health disorder (Crummy et 
al., 2020). As per (McCollister et al., 2017) study, substance 
use disorders (SUDs) represent as much of  an economic 
impact, at an annual cost to the United States, of  over 
$740 billion for healthcare expenses, lost productivity, 

and criminal justice costs. Drug use occurs in a variety 
of  population’s but have higher prevalence rates and 
barriers to treatment in young adults, and marginalized 
communities (Mongelli et al., 2020). 
Legal changes, technological development and cultural 
changes have all paid a part in making drugs available 
without restriction in the United States. The study by 
(Hammond et al., 2020) emphasized that 7.6 million 
Americans reported using cannabis, an increase triggered 
in large part by marijuana legalization at the state level, 
and misuse and dependency rates were edging up, notably 
among young adults. But beyond cannabis, the internet 
and dark web make it easier to buy more, ranging from 
synthetic opioid to designer drug, all with anonymous 
purchases that rarely traverse traditional law enforcement 
channels (McCollister et al., 2017). Increased access 
has extended to the internet and the dark web, where 
it is estimated that some 2.5 million Americans acquire 
drugs online each year, including high-risk drugs like 
synthetic opioids (Lokala et al., 2022). Besides being 
more accessible, prescription medications like opioids 
and stimulants are also becoming widely available over 
telemedicine and online pharmacies, raising fears of  over-
prescription and abuse (McCann, 2020). These impacts 
are social communities experiencing increased crime, 
homelessness, and family disruption. 



Pa
ge

 
2

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 1-8, 2025

Although, there are complex challenges in managing 
psychiatric and behavioral disorders associated with a 
drug use in the United States, high prevalence rates of  
SUDs often coexist among mental health conditions 
(McCabe et al., 2017). Yule and Kelly (2019) highlighted 
that individuals with comorbid mental health disorders 
including depression, anxiety or schizophrenia also 
struggle to treat their addiction, with many resulting to 
turn to drug or alcohol for coping. Together these different 
deterrents add to the stigma surrounding mental health 
and drug use, which discourages individuals from seeking 
help, and especially in underserved communities with few 
mental health services (Drew & Martin, 2021). This study 
aims to understand the adverse mental health burden of  
unrestricted drug use in the United States with regard to 
the relationship with the development of  psychiatric and 
behavioral disorders. It examines the number of  mental 
health disorders that are drug use related, the influence of  
the accessibility of  drugs on those health issues, whether 
there an association of  certain drugs and specific mental 
health problems, and identification of  prevention and 
intervention strategies to prevent or alleviate certain crises 
of  mental health because of  the misuse of  the drugs.

MATERIALS AND METHODS
This work relies mainly on a primarily quantitative 
approach to assess the effects of  the liberal use of  
drugs on psychiatric and behavioural disorders with a 
particular emphasis on mental health in the United States. 
The following is a description of  the research design, 
the method of  selecting the sample, the data collection 
techniques, and the analysis plan to facilitate clarity and 
replication.

Research design
This study adopts a cross-sectional survey design to 
survey the connection between the unrestricted use of  
drugs and its impact on the disorders of  the psychiatric 
and behavioural systems in the United States. The 
current study’s cross-sectional research design allows the 
accumulation of  data from a diverse population within 
a certain period, which makes it easier to determine the 
relationship between variables (Aljarallah et al., 2023). 
The research primarily adopts a quantitative approach 
because it allows the collection of  numerical data that 
can be analysed statistically. This design is especially 
appropriate for studying drug use behaviours and their 
mutual relations with mental health outcomes, based on 
the findings of  empirical research.

Sample size and selection
The participants for this study are 378, based on the 
estimation to provide enough power for the test. The 
target participants are recruited through convenience 
sampling from several social media platforms to achieve a 
large sample and variability. Recruitment is done through 
Facebook, forums for people with mental health issues, 
and postings on bulletin boards. Participants eligible 

for the study are any adult at least 18 years of  age and 
a resident of  the United States. These are the specific 
inclusion criteria set for this research to increase the 
chances of  the sample representing the target population 
(MM Rahman, 2023). An attempt is made to ensure 
that participants are selected from different age groups 
and genders, ethnicities, and socio-economic classes to 
increase the study’s external validity.

Data collection
The data is generated by administering a self-completed 
online questionnaire that provides quantitative data on 
drug use, psychiatric state, and behavioural problems. 
The survey uses closed-ended questions that will elicit 
standardised responses that can be quantitatively analysed 
(Alam, 2020). It is divided into topics such as demographic 
details, rate and kind of  drug use, as well as self-identified 
psychological disorders. Self-report scales, including but 
not limited to the 

Data analysis
The survey data collected is analyzed using Statistical 
Package for the Social Sciences (SPSS) software (Okagbue 
et al., 2021). Demographic data and the participant’s 
substance use history are summarised using measures such 
as mean, frequency, and standard deviation. Descriptive 
statistical methods, correlation analysis, regression 
analysis, t-tests, etc., are used to study the association 
between drug use and various psychiatric and behavioural 
disorders (Casella & Berger, 2024). Data management has 
become very efficient in SPSS, and the accuracy of  the 
dataset cannot be questioned while processing it (Pallant, 
2020). Moreover, chi-square tests are also used to test 
relationships between categorical variables, such as drug 
type and specific psychiatric symptoms.

Ethical considerations
A recognised IRB approves the study’s academic and 
practical aspects to ensure compliance with the research 
ethics (Hayes, 2020). An informed consent form displayed 
at the onset of  the online survey informs participants 
about the purpose, processes, and measures taken 
regarding privacy. All the respondents are volunteers and 
are free to pull out at any given time without repercussions. 
To ensure privacy, all data is anonymous, and the survey 
tool is set up so that no identifiable information, such as 
IP address, can be collected.

Strengths and limitations
Regarding the advantages of  the chosen methodology, 
the following can be noted: accessibility of  the web 
as a source of  information, relatively low cost of  the 
experiment, and the opportunity to reach many people 
from different geographical locations. Using the online 
survey format provides easy sample recruitment and 
helps in fast data collection. However, some limitations 
should be mentioned. The use of  self-reported data 



Pa
ge

 
3

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 1-8, 2025

adds the possibility of  response biases like under or 
over-reporting of  drug use or psychiatric symptoms. 
Furthermore, the study’s cross-sectional nature and 
convenience sampling may reduce the generalisation of  
the results. Nevertheless, the above limitations can be 
considered acceptable in light of  the research aims and 
objectives for developing an understanding of  the effects 
of  drug use on mental health.

RESULTS AND DISCUSSIONS
The results section provides demographic data, 
perceptions of  the effects of  drug use, and inter-observer 
reliability of  the employed scales. It includes age and 
gender distribution, response to statements on mental 
health and its social aspect, the validity of  the knowledge 
scale, mental health scale, social influence scale, and 
treatment efficacy scale.

Table 1: Frequency Table
Age

Frequency Percent Valid Percent Cumulative Percent
Valid 18-24 years 23 6.1 6.1 6.1

24-30 years 90 23.8 23.8 29.9
31-36 years 147 38.9 38.9 68.8
37-44 years 93 24.6 24.6 93.4
45 years and above 25 6.6 6.6 100.0
Total 378 100.0 100.0

Table 2: Gender
Gender

Frequency Percent Valid Percent Cumulative Percent
Valid Male 229 60.6 60.6 60.6

Female 149 39.4 39.4 100.0
Total 378 100.0 100.0

Table 3: Descriptive Statistics
Descriptive Statistics

N Minimum Maximum Mean Std. Deviation
Drug abuse is a leading cause of  behavioral 
disorders in the United States.

378 1.00 5.00 3.4709 1.07316

Most individuals are aware of  the mental health 
risks associated with drug misuse.

378 1.00 5.00 3.5688 1.03354

There is sufficient public education about the 
psychiatric implications of  drug use.

378 1.00 5.00 3.5291 1.06073

Unrestricted drug use leads to long-term 
psychiatric disorders, such as anxiety and 
depression.

378 1.00 5.00 3.7937 .79438

Behavioral disorders like aggression and 
impulsivity are often linked to substance abuse.

378 1.00 5.00 3.8571 .79168

The age frequency table below indicates the number of  
respondents in every age group. Most of  the participants, 
38.9%, are between 31 and 36 years old and, therefore, 
can be deemed the largest group in this study. The 
second largest age group is 37-44 years, 24.6%. The third 
largest age group is between 24-30 years which is 23.8%. 

Participants aged 18 years and below makeup only 6.1% 
of  the study population, while those 45 years and above 
also form only 6.6%. This data is dominated by middle-
aged participants, which may cause a bias in the results if  
experiences or attitudes toward drug use differ depending 
on age. 

The gender frequency table shows that the sample 
includes more males, 60.6%, compared to females, 
39.4%. Such a situation may be attributed to demographic 
characteristics or study recruitment methods. Participants 

included both males and females, though a more 
significant number of  male participants could be seen as 
limitative in terms of  gender-specific perception of  drug 
use and its consequences.



Pa
ge

 
4

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 1-8, 2025

Drug use increases the likelihood of  developing 
psychosis or similar mental health conditions.

378 1.00 5.00 3.8016 .78128

Co-occurring mental health and substance use 
disorders are a growing concern in society.

378 1.00 5.00 3.8466 .74830

Unrestricted drug use negatively affects family 
dynamics and relationships.

378 1.00 5.00 3.5053 .95313

Communities suffer significant economic 
consequences due to drug-related mental 
health issues.

378 1.00 5.00 3.3757 1.04368

The stigma surrounding mental health and 
drug use prevents effective treatment.

378 1.00 5.00 3.7381 .86957

Increased availability of  drugs correlates with a 
rise in violent or criminal behaviors.

378 1.00 5.00 3.7778 .84836

There are sufficient resources for treating 
psychiatric disorders caused by drug use.

378 1.00 5.00 3.8730 .79438

Early intervention programs are effective in 
reducing the mental health impact of  drug use.

378 1.00 5.00 3.8280 .79090

Restricting drug availability could decrease the 
prevalence of  behavioral disorders.

378 1.00 5.00 3.8254 .81510

Mental health services should prioritize 
addressing the impact of  drug use.

378 1.00 5.00 3.8519 .75641

Valid N (listwise) 378

The table of  descriptive statistics contains the participants’ 
ratings of  statements regarding the effects of  drug use on 
mental health. The results on the Likert scale (1-5) mean 
score are between 3.37 and 3.87, all above the middle 
point, indicating that the participants agree with the 
statements. The highest mean score reflects the statement 
for treating psychiatric disorders associated with the use 
of  drugs, which can be interpreted as a positive attitude 
about the availability of  treatments. As is the case with 
the previous statements, means for statements about 
mental illnesses and substance use disorders (3.85), the 
necessity of  focusing on mental health services (3.85), 
and the connection between substance use disorders 
and behavioral disorders (3.86) are high. The results 
of  the current study provide support for the assertion 
that participants understand the relationship between 

substance use and mental health issues. A relatively weaker 
consensus is indicated by lower mean scores like 3.37 for 
the statement regarding the economic effects of  drug-
related mental health issues. This is shown in the standard 
deviations, which are 0.74 – 1.07. As earlier mentioned, 
statements like co-occurring disorders and psychosis have 
a slight standard deviation (0.74-0.79), which shows that 
there is consistency in the response. On the other hand, 
the scores of  statements about public education (1.04) 
and economic consequences (1.04) are more volatile as 
the participants have perceived differently. These statistics 
give an insight into how people perceive drug use and 
mental health problems.

Scale: Knowledge and Awareness

Table 4: Reliability Statistics
Reliability Statistics
Cronbach's Alpha N of  Items
.865 4

Cronbach’s Alpha for the knowledge and awareness scale is 
0.865, which shows good reliability. This implies that all the 
items in this scale provide a valid indication of  participants’ 

knowledge regarding drug use and its consequences.

Scale: Mental Health Implications

Table 5: Reliability Statistics
Reliability Statistics
Cronbach's Alpha N of  Items
.731 4



Pa
ge

 
5

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 1-8, 2025

The mental health implications scale has acceptable levels 
of  reliability, as shown by Cronbach’s Alpha of  0.731. This 
indicates that the items successfully measure the participants’ 

knowledge of  the effects of  drug use on mental health.

Scale: Social and Economic Impact

Table 6: Reliability Statistics
Reliability Statistics
Cronbach's Alpha N of  Items
.775 4

Table 7: Reliability Statistics
Reliability Statistics
Cronbach's Alpha N of  Items
.807 4

The scale measuring social and economic impacts has 
Cronbach’s alpha coefficient of  0.775. Therefore, it is 
reliable. The items do tap into the perceptions of  other 

social and financial implications of  drug use.

Scale: Treatment and Prevention

The reliability of  the treatment and prevention scale is 
tested using Cronbach’s Alpha with a value of  0.807. 
This is in concordance with responses to questions on 
the adequacy and effectiveness of  intercessions in the 
reduction of  mental health consequences of  substance use.

Discussion 
The study sheds light on the complex relationship between 
unrestricted drug use and its impact on mental health, 
highlighting participants’ perceptions of  the challenges 
posed by substance abuse. The findings provide a 
comprehensive picture of  the issue by examining key 
areas such as awareness, psychiatric implications, societal 
consequences, and the adequacy of  treatment and 
prevention efforts. These insights align with existing 
literature, offering essential impact on public health 
policies and interventions.

Public Awareness of  Risks
A significant theme emerging from the study is the 
participants’ awareness of  the risks associated with drug 
misuse. Most respondents recognized the connection 
between substance abuse and its harmful effects on 
mental health. This general awareness reflects findings 
from Nawi et al. (2021), which emphasized that knowledge 
about the dangers of  drug use is crucial for reducing its 
prevalence. Public understanding of  drug-related risks 
is often shaped by education campaigns, which have 
gained prominence in recent years. However, the study 
also uncovered varying perceptions about the adequacy 
of  public education on the psychiatric implications of  
drug use. This inconsistency mirrors critiques of  Bercaw 
et al. (2022), which highlighted the limited reach of  some 
campaigns, particularly in marginalized communities. 
While awareness of  general risks appears strong, the 
nuanced understanding of  specific consequences, such 
as long-term mental health effects, remains uneven. 
Strengthening educational initiatives tailored to diverse 

audiences could enhance the public’s ability to make 
informed choices, particularly in areas where drug misuse 
is prevalent.

The Connection Between Substance Abuse and 
Mental Illness
There was harmonious recognition of  the severe impact 
of  drug abuse on mental health among participants. 
The research also reestablishes the relationship between 
substance use and mental illness, including anxiety, 
depression, and psychosis. The preceding findings tally 
with Price (2020), who pointed out that substance use 
is a risk factor for poor mental health. Since chronic 
drug exposure affects brain function, it makes the 
users vulnerable to these conditions, as described by 
Salmanzadeh et al. (2020). Mental health and substance 
use disorders were the fastest-growing dual diagnoses to 
surface. This coexistence of  these two disorders makes 
it difficult to treat and manage the affected persons. 
According to van (2023), the National Institute on Drug 
Abuse, these issues must be solved through the integrated 
care model. The latter was evident in perceptions 
expressed by participants who acknowledged the need 
for integrated care models that address the multiple 
needs of  users. Although the results also show that most 
participants agree with the statements stating that drug 
misuse has adverse effects on mental health, variation 
across participants’ responses to these statements might 
indicate differences in their perception. For instance, 
participants had slightly divergent views on the degree 
to which early intervention can help prevent psychiatric 
effects. These variations may be due to different 
experiences with the treatment or Different education on 
mental health status.

Peoples and Existing Economy Impacts of  
Substance Use
Alcoholism and drug addiction are not limited to the 



Pa
ge

 
6

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 1-8, 2025

individual, but rather, it has widespread effects on families, 
communities, and even within the society. They both 
pointed out that participants were aware of  the stress 
that drug misuse has on relationships and interactional 
patterns. These results are consistent with MI Naples 
(2021), which pointed out that drug use in the United 
States was costing hundreds of  billions of  US dollars 
annually through healthcare costs, reduced productivity, 
and criminal justice costs. However, the study failed to 
establish whether the participants had any awareness 
of  the economic impact of  drug-related mental health 
problems. Concerning financial consequences, the mean 
ratings given to statements were a little lower than those 
given to other items. These differences are consistent 
with the observation that people’s discussions mainly 
focus on the consequences for themselves and not on the 
overall economy (Drupp et al., 2021). Enhancing people’s 
knowledge of  the economic consequences of  substance 
abuse might expand the community’s involvement in 
programs to prevent substance use and support recovery. 
The study also reveals that participants experienced many 
prejudices related to substance use and mental health that 
act as a barrier to the treatment process. This observation 
is consistent with the findings of  Na et al. (2024), who 
stressed that stigma discourages people from seeking 
support and weakens the impact of  community health 
programs. Stigma reduction is significant when it comes 
to education and community involvement, as people 
embrace those affected and accept them back into society.

Treatment and Prevention: Optimism and Gaps
Regarding the availability of  resources, participants 
seemed to have faith in the available resources and also 
the early intervention programs, stating that there exist 
enough resources to deal with mental health due to 
substance use. This concurs with Thapar et al. (2022), 
who noted that preventive interventions, if  sustained 
in the long term, were more advantageous, especially 
for the young population. With early intervention, it is 
possible to interrupt the continuum of  substance use 
and related mental health consequences, thus lessening 
the total disease load on the healthcare system. However, 
these findings also highlighted differences in the 
perceived treatment adequacy between the two groups. 
In terms of  access to mental health services, participants 
observed that it was inconsistent, especially concerning 
marginalised communities. This finding is supported 
by the Substance Abuse and Mental Health Services 
Administration, which pointed out that rural and low-
income populations are the most deprived of  access to 
care (Reilly, 2021). Increasing the scope of  telemedicine-
related activities and extending community programs can 
help overcome these gaps, avoiding any person’s lack of  
necessary resources. Another recognizable theme was 
the emphasis on the importance of  the integrated care 
approach to treating dual diagnosis. They stressed that 
mental health services should be incorporated into more 
general health care systems. This aligns with the World 

Health Organisation’s recent push to move substance 
abuse treatment into primary care contexts (World 
Health Organisation, 2020). Integrated care models of  
treating mental health and substance use can enhance the 
treatment results and minimize the patient’s relapse.

Substance Abuse: A Holistic View
The results of  this study provide a clear picture of  the 
various ways in which drug abuse affects mental health 
and society. There is consensus from the participants’ 
responses about the need for specific strategies, education, 
and fair distribution of  resources. Such observations are 
in line with various research studies, which highlight that 
a global approach should be used to tackle the issue of  
substance use. Jemberie et al. (2020) pointed out that 
the management of  substance use should be focused 
on prevention, treatment, and community mobilisation. 
The conclusion of  this study can affirm the presented 
perspective concerning individual and societal dynamics. 
For instance, the participants’ recognition of  the social 
and economic impacts of  substance use shows that there 
should be policies that deal with the causes of  substance 
abuse, including poverty and illiteracy (Amaro et al., 2021). 
The study also also also emphasises the importance of  
public awareness in the creation of  attitudes toward drug 
use. Participants understand general risk, but knowledge 
deficits related to specific areas, such as the economic 
impact, are evident. Targeted education campaigns could 
help reduce these gaps and promote a better-informed 
society and better able to act in its interests.

Policy and practice implications
The findings of  this study have the following policy, 
practice, and community implications for policymakers, 
healthcare practitioners, and community stakeholders. 
First, the findings call for improved public awareness 
campaigns that focus on the risks associated with drug 
use to the user and the whole society. Therefore, the 
campaigns should be targeted to different audiences 
so that the stakeholders can help enhance people’s 
awareness of  various issues to encourage healthier 
choices. Second, detecting the dual diagnosis emphasizes 
the need for an integrated treatment approach. The 
authors also recommend that the funding should go 
to programs that address mental health and substance 
use disorders (Alegría & Frank, 2024). Integrated care 
contributes not only to the better situation of  a particular 
patient but also to the decrease in overall demands on a 
healthcare system. Third, the variation in the perceived 
adequacy of  treatment means that resources should be 
distributed. Teledermatology, m-Health, health fairs, and 
continuing medical education for physicians may be ways 
of  providing care in underserved areas. Thus, the increase 
in the availability of  mental health services is crucial for 
meeting the needs arising from substance abuse. Lastly, 
reducing stigma is still an important issue of  concern. 
The study shows that stigma in society regarding mental 
illness and substance use is still a significant barrier to 



Pa
ge

 
7

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 1-8, 2025

the advancements of  treatment and rehabilitation. The 
stakeholders can develop a system that encourages people 
to find support and recover thanks to the focus on open 
discussion and involving the public.

CONCLUSION 
This study aimed to identify the effects of  unrestricted 
drug use on psychiatric and behaviour disorders in the 
United States for the chosen themes during primary 
quantitative methodology, including awareness, mental 
health effects, social impact, treatment, and preventive 
measures. The results also show the importance of  the 
substance abuse treatment dilemma and the multifaceted 
impact of  the disorder on people, families, and societies. 
The participants had a good general knowledge about 
some of  the dangers of  substance abuse and the 
relationship between substance abuse and psychiatric 
disorders, including anxiety, depression, and psychosis. 
Nonetheless, there are also weaker points in the fine-
tuning of  the understanding, including the issue of  the 
economic cost and the sufficiency of  the public schools. 
Early intervention and availability of  treatment were 
two things that most of  the respondents agreed on, 
as expressed in this study. However, still, the finding 
indicated that equal access to treatment is still a big 
concern, especially for the minority population. Mental 
health and substance use disorders were found to coexist, 
and the strategies that were named as important included 
integrated care approaches and equitable distribution 
of  mental health services. Also noteworthy was the 
identification of  the problem of  prejudice associated 
with taking drugs and having mental disorders, which 
prevents people from seeking help. The study resonates 
with empirical literature to emphasize the importance of  
integrated and complex approaches toward addressing 
the mental health effects of  drug abuse. Public awareness, 
polyclinical care, and fair distribution of  resources need 
to be taken up by policymakers and healthcare managers. 
Through supporting such changes and implementing 
evidence-based policies and interventions to overcome 
such challenges, the stakeholders involved can enhance 
the community’s outlook and handle substance use 
disorders and related mental health complications. 

REFERENCE 
Alam, M. K. (2020). A systematic qualitative case study: 

Questions, data collection, NVivo analysis and 
saturation. Qualitative Research in Organizations and 
Management: An International Journal, 16(1), 1–31. 
https://doi.org/10.1108/QROM-09-2019-1825

Azofeifa-Ujueta, A. (2023). Assessing and characterizing 
marijuana use disorders (DSM-5)—National survey on drug 
use and health, United States, 2020. Western Michigan 
University.

Azofeifa, A. (2019). Driving under the influence of  
marijuana and illicit drugs among persons aged ≥ 16 
years—United States, 2018. MMWR. Morbidity and 
Mortality Weekly Report, 68.

Alegría, M., & Frank, R. G. (2024). Policymakers should 
prioritize funding for programs that combine mental health and 
substance abuse treatment. Google Scholar.

Ali, A. M., Alkhamees, A. A., Hori, H., Kim, Y., & 
Kunugi, H. (2021). The Depression Anxiety Stress 
Scale 21: Development and validation of  the 
Depression Anxiety Stress Scale 8-item in psychiatric 
patients and the general public for easier mental 
health measurement in a post COVID-19 world. 
International Journal of  Environmental Research and Public 
Health, 18(19), 10142. https://doi.org/10.3390/
ijerph181910142

Aljarallah, N. A., Almuqbil, M., Alshehri, S., Khormi, 
A. M. S., AlReshaidan, R. M., Alomran, F. H., 
Fawzan Alomar, N., Alshahrani, F. F., Alshammari, 
M. S., Alsanie, W. F., Alhomrani, M., Alamri, A. S., 
& Asdaq, S. M. B. (2023). Satisfaction of  patients 
with health care services in tertiary care facilities of  
Riyadh, Saudi Arabia: A cross-sectional approach. 
Frontiers in Public Health, 10. https://doi.org/10.3389/
fpubh.2022.1077147

Amaro, H., Sanchez, M., Bautista, T., & Cox, R. (2021). 
Social vulnerabilities for substance use: Stressors, 
socially toxic environments, and discrimination and 
racism. Neuropharmacology, 188, 108518. https://doi.
org/10.1016/j.neuropharm.2021.108518

Bercaw, L. E., Levinson, A., Fletcher, D., Shuman, S. 
B., Hughes, S., Peddada, S., & Walsh, E. G. (2022). 
Assessing disparities in Medicaid home- and 
community-based services: A systematic review. 
Journal of  Aging & Social Policy, 1–20. https://doi.org/
10.1080/08959420.2022.2081424

Casella, G., & Berger, R. (2024). Statistical inference. Google 
Books.

Crummy, E. A., O’Neal, T. J., Baskin, B. M., & Ferguson, 
S. M. (2020). One is not enough: Understanding and 
modeling polysubstance use. Frontiers in Neuroscience, 
14, 569.

Drew, J. M., & Martin, S. (2021). A national study of  police 
mental health in the USA: Stigma, mental health and 
help-seeking behaviors. Journal of  Police and Criminal 
Psychology, 36(2), 295–306.

Drupp, M. A., Kornek, U., Meya, J. N., & Sager, L. (2021). 
Inequality and the environment: The economics of  a two-headed 
hydra. Econstor. http://hdl.handle.net/10419/248992

Hayes, A. F. (2020). Statistical methods for communication science. 
Routledge. https://doi.org/10.4324/9781410613707

Jemberie, W. B., Stewart Williams, J., Eriksson, M., 
Grönlund, A. S., Ng, N., Blom Nilsson, M., Padyab, 
M., Priest, K. C., Sandlund, M., Snellman, F., McCarty, 
D., & Lundgren, L. M. (2020). Substance use disorders 
and COVID-19: Multi-faceted problems which 
require multi-pronged solutions. Frontiers in Psychiatry, 
11. https://doi.org/10.3389/fpsyt.2020.00714

Larkin Jr, P. J., & Madras, B. K. (2019). Opioids, overdoses, 
and cannabis: Is marijuana an effective therapeutic 
response to the opioid abuse epidemic? Georgetown 
Journal of  Law & Public Policy, 17, 555.



Pa
ge

 
8

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 1-8, 2025

MI Naples. (2021, March 8). About. HeinOnline. 
Retrieved from https://heinonline.org/
HOL/LandingPage?hand le=he in . jour na l s/
rutjulp19&div=15&id=&page=

Rahman, M. M. (2023). Sample size determination 
for survey research and non-probability sampling 
techniques: A review and set of  recommendations. 
Journal of  Entrepreneurship, Business and Economics. 
Retrieved from https://www.scientificia.com/index.
php/JEBE/article/view/201

McCabe, S. E., West, B. T., Jutkiewicz, E. M., & 
Boyd, C. J. (2017). Multiple DSM-5 substance use 
disorders: A national study of  US adults. Human 
Psychopharmacology: Clinical and Experimental, 32(5), 
e2625. https://doi.org/10.1002/hup.2625

McCann, J. D. (2020). Do no good: How controlled 
substance regulations prohibit the use of  telemedicine 
to provide medication-assisted therapy for opioid use 
disorder. Tulsa Law Review, 56, 313.

McCollister, K., Yang, X., Sayed, B., French, M. T., Leff, J. 
A., & Schackman, B. R. (2017). Monetary conversion 
factors for economic evaluations of  substance use 
disorders. Journal of  Substance Abuse Treatment, 81, 25–
34. https://doi.org/10.1016/j.jsat.2017.07.001

Mongelli, F., Georgakopoulos, P., & Pato, M. T. (2020). 
Challenges and opportunities to meet the mental 
health needs of  underserved and disenfranchised 
populations in the United States. Focus, 18(1), 16–24. 
https://doi.org/10.1176/appi.focus.20190035

Na, B., Jiwon, J., & Park. (2024). APA PsycNet. 
Retrieved from https://psycnet.apa.org/
fulltext/2022-40012-001.html

Nawi, A. M., Ismail, R., Ibrahim, F., Hassan, M. R., 
Manaf, M. R. A., Amit, N., Ibrahim, N., & Shafurdin, 
N. S. (2021). Risk and protective factors of  drug 
abuse among adolescents: A systematic review. BMC 
Public Health, 21(1). https://doi.org/10.1186/s12889-
021-11906-2

Okagbue, H. I., Oguntunde, P. E., Obasi, E. C. 
M., & Akhmetshin, E. M. (2021). Trends and 
usage pattern of  SPSS and Minitab software in 
scientific research. Journal of  Physics: Conference Series, 
1734(1), 012017. https://doi.org/10.1088/1742-
6596/1734/1/012017

Pallant, J. (2020). SPSS survival manual. 
Preuss, C. V., Kalava, A., & King, K. C. (2019). Prescription 

of  controlled substances: Benefits and risks.
Price, A. (2020). Online gambling in the midst of  

COVID-19: A nexus of  mental health concerns, 
substance use, and financial stress. International Journal 
of  Mental Health and Addiction, 20(1). https://doi.
org/10.1007/s11469-020-00366-1

Reilly, M. (2021). Health disparities and access to 
healthcare in rural vs. urban areas. Theory in Action, 
14(2), 6–27. https://doi.org/10.3798/tia.1937-
0237.2109

Salmanzadeh, H., Ahmadi-Soleimani, S. M., Pachenari, 
N., Azadi, M., Halliwell, R. F., Rubino, T., & Azizi, 
H. (2020). Adolescent drug exposure: A review of  
evidence for the development of  persistent changes in 
brain function. Brain Research Bulletin, 156(1), 105–117. 
https://doi.org/10.1016/j.brainresbull.2020.01.007

Thapar, A., Eyre, O., Patel, V., & Brent, D. (2022). 
Depression in young people. The Lancet, 400(10352), 
617–631. https://doi.org/10.1016/s0140-
6736(22)01012-1

Van. (2023). Tackling addiction with integrated care. Open 
Journal of  Therapy and Rehabilitation, 11(3), 122–147. 
https://doi.org/10.4236/ojtr.2023.113010

World Health Organization. (2020). Operational framework 
for primary health care: Transforming vision into action. 
Retrieved from https://iris.who.int/bitstream/hand
le/10665/337641/9789240017832-eng.pdf


